Bristol Myers Squibb (BMY) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
-36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.04% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
31.95% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.77% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-25.38% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
73.24% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
12.50% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-22.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
33.46% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
33.46% |
| Dec 31, 2025 |
-2.12% |
| Sep 30, 2025 |
-1.23% |
| Jun 30, 2025 |
37.79% |
| Mar 31, 2025 |
-8.45% |
| Dec 31, 2024 |
14.55% |
| Sep 30, 2024 |
-5.26% |
| Jun 30, 2024 |
1.16% |
| Mar 31, 2024 |
2.16% |
| Dec 31, 2023 |
-4.62% |
| Sep 30, 2023 |
38.46% |
| Jun 30, 2023 |
-4.78% |
| Mar 31, 2023 |
9.88% |
| Dec 31, 2022 |
8.13% |
| Sep 30, 2022 |
-8.52% |
| Jun 30, 2022 |
29.52% |
| Mar 31, 2022 |
46.24% |
| Dec 31, 2021 |
13.07% |
| Sep 30, 2021 |
76.47% |
| Jun 30, 2021 |
60.31% |
| Mar 31, 2021 |
-6.99% |
| Dec 31, 2020 |
12.75% |
| Sep 30, 2020 |
-19.47% |
| Jun 30, 2020 |
-31.41% |
| Mar 31, 2020 |
-8.82% |
| Dec 31, 2019 |
-13.45% |
| Sep 30, 2019 |
-15.18% |
| Jun 30, 2019 |
-3.54% |
| Mar 31, 2019 |
-14.64% |
| Dec 31, 2018 |
14.17% |
| Sep 30, 2018 |
-14.50% |
| Jun 30, 2018 |
-20.16% |
| Mar 31, 2018 |
-17.87% |
| Dec 31, 2017 |
-31.54% |
| Sep 30, 2017 |
-23.17% |
| Jun 30, 2017 |
-4.98% |
| Mar 31, 2017 |
20.25% |
| Dec 31, 2016 |
30.18% |
| Sep 30, 2016 |
45.73% |
| Jun 30, 2016 |
58.18% |
| Mar 31, 2016 |
77.94% |
| Dec 31, 2015 |
49.21% |
| Sep 30, 2015 |
118.69% |
| Jun 30, 2015 |
50.00% |
| Mar 31, 2015 |
15.25% |
| Dec 31, 2014 |
-4.50% |
| Sep 30, 2014 |
-13.71% |
| Jun 30, 2014 |
12.24% |
| Mar 31, 2014 |
2.61% |
| Dec 31, 2013 |
14.29% |
| Sep 30, 2013 |
-9.49% |
| Jun 30, 2013 |
-13.27% |
| Mar 31, 2013 |
-6.50% |
| Dec 31, 2012 |
30.60% |
| Sep 30, 2012 |
63.10% |
| Jun 30, 2012 |
52.70% |
| Mar 31, 2012 |
64.00% |
| Dec 31, 2011 |
7.20% |
| Sep 30, 2011 |
-5.62% |
| Jun 30, 2011 |
-8.64% |
| Mar 31, 2011 |
-41.86% |
| Dec 31, 2010 |
-36.22% |
| Sep 30, 2010 |
-47.34% |
